Pharma and biotech jostle to produce vaccine as swine influenza spreads
This article was originally published in Scrip
Executive Summary
Several firms are scrambling for a strain of the swine influenza A (H1N1) virus that has left officials fearing a pandemic, Scrip has learnt. Pharma and vaccine firms have been in regular contact with the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) about producing a vaccine to combat the outbreak.